Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: An effect on sepsis-induced immunosuppression

International Journal of Antimicrobial Agents

Volumn 45, Issue 4, 2015, Pages 376-384

  Machairas, Nikolaos ^a   Pistiki, Aikaterini ^a   Droggiti, Dionyssia Irini ^a   Georgitsi, Marianna ^a   Pelekanos, Nikolaos ^a   Damoraki, Georgia ^a   Kouraklis, Grigorios ^a   Giamarellos Bourboulis, Evangelos J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Interleukin 10; Probiotics; Pseudomonas aeruginosa; Sepsis; SOCS3; Tumour necrosis factor alpha

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; PROBIOTIC AGENT; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; APOPTOSIS; ARTICLE; BACTERIAL OVERGROWTH; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; C57BL 6 MOUSE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG MECHANISM; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LEUKOCYTE; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RAT; RODENT; SACCHAROMYCES BOULARDII; SEPSIS; SPLEEN CELL; SURVIVAL; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MONONUCLEAR CELL; NORMAL HUMAN; PSEUDOMONAS INFECTIONS; SECRETION (PROCESS);

ANIMALS; CELLS, CULTURED; CYTOKINES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HEALTHY VOLUNTEERS; HUMANS; IMMUNE TOLERANCE; LEUKOCYTES, MONONUCLEAR; MALE; MICE, INBRED C57BL; PROBIOTICS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEPSIS; SURVIVAL ANALYSIS;

EID: 84925500919     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.11.013     Document Type: Article

References (20)

1. D. Barraud, C. Blard, F. Hein, O. Marcon, A. Cravoisy, and L. Nace Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial Intensive Care Med 36 2010 1540 1547
2. P.K. Jain, C.E.Naught, A.D. Anderson, J. MacFie, and C.J. Mitchell Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial Clin Nutr 23 2004 467 475
3. C. Forestier, D. Guelon, V. Cluytens, T. Gillart, J. Sirot, and C. De Champs Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients Crit Care 12 2008 R69
4. D.J. Knight, D. Gardiner, A. Banks, S.E. Snape, V.C. Weston, and S. Bengmark Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial Intensive Care Med 35 2009 854 861
5. K. Kotzampassi, E.J. Giamarellos-Bourboulis, A. Voudouris, P. Kazamias, and E. Eleftheriadis Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: early results of a randomized controlled trial World J Surg 30 2006 1848 1855
6. K. Shimizu, H. Ogura, M. Goto, T. Asahara, K. Nomoto, and M. Morotomi Synbiotics decrease the incidence of septic complications in patients with severe SIRS: a preliminary report Dig Dis Sci 54 2009 1071 1078
7. M. Tan, J.C. Zhu, J. Du, L.M. Zhang, and H.H. Yin Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study Crit Care 15 2011 R290
8. L.E. Morrow, M.H. Kollef, and T.B. Casale Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial Am J Respir Crit Care Med 182 2010 1058 1064
9. K. Kotzampassi, and E.J. Giamarellos-Bourboulis Probiotics for infectious diseases: more drugs, less dietary supplementation Int J Antimicrob Agents 40 2012 288 296
10. H. Tsujimoto, S. Ono, P.A. Efron, P.O. Scumpia, L.L. Moldawer, and H. Mochizuki Role of Toll-like receptors in the development of sepsis Shock 29 2008 315 321
11. J.S. Boomer, K. To, K.C. Chang, O. Takasu, D.F. Osborne, and A.H. Walton Immunosuppression in patients who die of sepsis and multiple organ failure JAMA 306 2011 2594 2605
12. E.J. Giamarellos-Bourboulis, F. van de Veerdonk, M. Mouktaroudi, M. Raftogiannis, A. Antonopoulou, and L.A.B. Joosten Inhibition of caspase-1 activation in Gram-negative sepsis and experimental endotoxemia Crit Care 15 2011 R27
13. E.J. Giamarellos-Bourboulis, S. Bengmark, K. Kanellakopoulou, and K. Kotzampassi Pro- and synbiotics to control inflammation and infection in patients with multiple injuries J Trauma 67 2009 815 821
14. M.G. Besselink, H.C. van Santvoort, E. Buskens, M.A. Boermeester, H. van Goor, and H.M. Timmerman Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 371 2008 651 659
15. B. Sharma, S. Srivastava, N. Singh, V. Sachdev, S. Kapur, and A. Saraya Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: a double-blind randomized controlled trial J Clin Gastroenterol 45 2011 442 448
16. S. Eguchi, M. Takatsuki, M. Hidaka, A. Soyama, T. Ichikawa, and T. Kanematsu Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study Am J Surg 201 2011 498 502
17. Z.H. Liu, M.J. Huang, X.W. Zhang, L. Wang, N.Q. Huang, and H. Peng The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial Am J Clin Nutr 97 2013 117 126
18. H. Qin, A.T. Holdbrooks, Y. Liu, S.L. Reynolds, L.L. Yanagisawa, and E.N. Benveniste SOCS3 deficiency promotes M1 macrophage polarization and inflammation J Immunol 189 2012 3439 3448
19. E. Vahabnezhad, A.B. Mochon, L.J. Wozniak, and D.A. Ziring Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis J Clin Gastroenterol 47 2013 437 439
20. A. Mehta, S. Rangarajan, and U. Borate A cautionary tale for probiotic use in hematopoietic SCT patients - Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT Bone Marrow Tansplant 48 2013 461 462